Related Experiment Video
Updated: Aug 3, 2026

Analysis of the Development of a Morphological Phenotype as a Function of Protein Concentration in Budding Yeast
Published on: March 24, 2010
Expression of phenotypic traits following modulation of colchicine resistance in J774.2 cells
Abstract:
Development of resistance to colchicine in the mouse macrophage-like cell line J774.2 coincides with the expression of a variety of phenotypic traits. A cloned subline (J7/CLC-20), maintained in 20 microM colchicine, exhibits reduced steady-state association with drug, increased presence of a 140,000-145,000 dalton (140-145 kD) phosphoglycoprotein associated with the plasma membrane, double minute chromosomes and cross-resistance to other drugs. While similar phenotypic traits are observed in J774.2 cells resistant to taxol and vinblastine, differences in the electrophoretic mobilities of the resistance-specific glycoproteins in each of the three sublines suggest that multi-drug resistant sublines exhibit specificity for individual drugs. In an attempt to elucidate the relationships between the phenotypic traits associated with colchicine resistance, the degree of colchicine resistance in J7/CLC-20 cells was modulated and the levels of expression of the phenotypic traits were quantitated. In the absence of colchicine in the growth medium, J7/CLC-20 cells reverted to drug sensitivity within 35 days. A decrease in the level of resistance coincided with coordinate changes in both the quantity of the resistance-specific glycoprotein and the average number of double minute chromosomes. We propose that the emergence and disappearance of the resistance-specific glycoprotein and double minute chromosomes may be closely linked. However, J7/CLC-20 cells which had regained their drug sensitivity after growth in drug-free medium maintained a reduced level of steady-state drug association. The persistence of reduced drug association in cells that have reverted to a drug-sensitive state suggests that this phenomenon, although related to colchicine resistance, need not be the primary or only mechanism of drug resistance.
Insights
Mouse cells resistant to colchicine (a chemotherapy drug) developed specific protein markers and genetic changes. These changes reversed when the drug was removed, but reduced drug uptake persisted, suggesting complex resistance mechanisms.
Area of Science:
- Cell Biology
- Pharmacology
- Genetics
Background:
- Drug resistance is a major challenge in cancer chemotherapy.
- The mouse macrophage-like cell line J774.2 develops resistance to colchicine, a microtubule-targeting agent.
- Colchicine resistance is associated with specific phenotypic changes.
Purpose of the Study:
- To investigate the relationship between phenotypic traits and colchicine resistance in J774.2 cells.
- To quantify the expression levels of resistance-associated markers.
- To understand the mechanisms underlying drug resistance and its modulation.
Main Methods:
- Development of a cloned subline (J7/CLC-20) resistant to colchicine.
- Culturing cells in the presence and absence of colchicine.
- Quantification of drug association, glycoprotein expression, and double minute chromosomes.
Main Results:
- Colchicine-resistant cells (J7/CLC-20) showed reduced drug uptake, increased 140-145 kD phosphoglycoprotein, and double minute chromosomes.
- These traits, including drug resistance, reverted upon removal of colchicine.
- Reduced steady-state drug association persisted even after cells regained drug sensitivity.
Conclusions:
- The emergence of a specific glycoprotein and double minute chromosomes is closely linked to colchicine resistance.
- These markers and resistance are reversible upon drug withdrawal.
- Reduced drug association may be a related but not solely responsible mechanism for colchicine resistance.

